Frequently Asked Questions
Technical Questions
> Luciferase seems more convenient. Why and When should I use NIS?
Luciferase is an excellent reporter gene for ‘quick and dirty’ studies of cell or virus fate in SCID or nude mice. Up to five mice can be imaged at one time making luciferase an excellent screening tool, and small numbers of cells can be detected, but images are two-dimensional and resolution is poor.
Importantly, researchers from the University of Minnesota recently reported that firefly luciferase is immunogenic, resulting in substantial loss in gene expression levels in immunocompetent mice over time. Hence, luciferase is not desirable for long term cell tracking studies.
Reference: Cellular immune response against firefly luciferase after sleeping beauty-mediated gene transfer in vivo. Podetz-Pedersen KM, Vezys V, Somia NV, Russell SJ, McIvor RS. Hum Gene Ther. 2014 Nov;25(11):955-65. doi: 10.1089/hum.2014.048. Epub 2014 Sep 22. PMID:25093708
> Which reporter gene should I use for whole animal imaging?
Mice: you can use optical imaging (luciferase or fluorescent proteins) or nuclear imaging (NIS). Biolumonescence imaging is very sensitive and there is no issue with background signals. Due to issues with autofluorescence from fur or rodent chow, fluorescence imaging in living animals can be challenging as it requires you to first subtract the background fluorescence signals. If you want to obtain high resolution 3D true tomographic data, you should use nuclear reporter genes (e.g. NIS) with SPECT/CT or PET/CT imaging for best quantitative results.
Rats or larger: Due to inability of light to penetrate deep tissues and scatter, nuclear reporter genes (e.g. NIS) are the ideal genes for in-life imaging of living animals. If you need to monitor the genes long term, you will need to ensure that you use an immunogenic reporter gene (e.g. species specific NIS) to prevent host immune mediated rejection of NIS transduced cells.
> What is the difference between a p24 and qPCR titer?
A p24 titer is acquired via a p24 Gag antigen ELISA, whereas qPCR detects the amount of lentivirus DNA present in the sample.
Traditional p24 ELISA titrations measure both functional and non-functional lentivirus particles. However, it overestimates the functional titer, as the p24 protein pool includes a variable amount of free p24 and p24 associated with non-functional vector particles. The ratio can vary greatly between each lot so it is inherently inaccurate.
Following transduction, qPCR titration quantifies the number of lentivirus genome copies in a cell population as compared to a cellular reference gene. Absolute quantification via the standard curve method indicates the number of integrated genomes per cell. Thus, although qPCR titers are often lower than p24 titers, qPCR titration yields a more reliable functional titer.
> My biosafety office is asking me about RCV (replication competent virus). What is this?
Replication competent viruses (RCV) are virus particles capable of infection and production of infectious particles. Lentiviral vectors have been engineered to significantly reduce the likelihood of RCV production.
Our lentiviral transfer plasmids are self-inactivating (SIN) vectors in which the viral enhancer and promoter have been deleted. This increases biosafety by preventing mobilization of RCV and enabling regulated expression from the internal promoter without cis-acting effects of the LTR (Miyoshi et al., J Virol. 1998). This safety measure is combined with the 2nd generation packaging system which excludes accessory viral genes necessary for efficient replication and pathogenesis in vivo. Together, these safety precautions should prevent production of RCV.
However, the FDA requires that lentiviral stocks used in human clinical trials be tested for RCV, and some institutions have adopted this in their biosafety protocols. A p24 Gag antigen ELISA assay is most commonly used to demonstrate that there is no increase in p24 titer over time in the media of transduced cells. Imanis offers p24 ELISA RCV testing for lentiviruses, please see this page for more information.
> Can the OVs be administered to animals intravenously?
Yes! The Ovs are suspended in biocompatible media and can be injected intravenously into animals. We suggest dilution of viruses to desired dose level in sterile normal saline and kept on ice until use.
The high titer and high purity viral stocks (listed as High Titer) are prepared specially for in vivo antitumor efficacy experiments. Many of our clients (including our research team) find these high titer stocks very appealing for studies in mice.
> You have so many antibodies. Which one do I use?
Recommended Imanis antibodies: by target and application
Target |
Western blotting |
Immunofluorescence |
Flow cytometry |
Immunohistochemistry |
||
---|---|---|---|---|---|---|
Intact cells |
Permeabilized cells |
Intact cells |
Permeabilized cells |
|||
Human NIS |
SJ1 (REA004) |
VJ1 (REA002) VJ2 (REA003) |
ETNL (REA009) KELE (REA010)1 |
VJ1 (REA002) VJ2 (REA003) |
ETNL (REA009) Mouse a-hNIS (REA011) |
SJ1 (REA004) KELE (REA010)2 |
Rhesus NIS |
SJ1 (REA004) |
X |
SJ1 (REA004) |
X |
SJ1 (REA004) |
X |
Rat NIS |
α-rat NIS (REA008) |
X |
α-rat NIS (REA008) |
X |
α-rat NIS (REA008) |
α-rat NIS (REA008)3 |
Mouse NIS |
α-rat NIS (REA008) |
X |
α-rat NIS (REA008) |
X |
α-rat NIS (REA008) |
α-rat NIS (REA008)3 |
X = No antibody currently offered for this application.
1Dohan et al. Mol Endoclinol. 2006. 20:1121-1137
2Dohan et al. J Clin Endocrinol Metab. 2001. 86:2697-270
3Tazebay et al. Nat. Med. 2000. 6:871-878
> What generation are your lentiviruses? Why does generation matter?
Our lentiviruses are 2nd generation. Generation matters when considering which packaging plasmids to use to produce the lentivirus particles. Briefly, our lentiviral transfer plasmids are meant to be used in a 3 plasmid 2nd generation packaging system:
- Lentiviral transfer plasmid – the lentiviral plasmid encoding your transgene (ie. pLV-SFFV-hNIS)
- Packaging plasmid - encoding Gag, Pol, Rev, and Tat. Tat is essential for 2nd generation packaging.
- Envelope plasmid – encoding the envelope protein (usually VSV-G)
3rd generation lentiviruses encode Gag/Pol and Rev on 2 separate plasmids and the transfer plasmids are Tat independent. Thus 2nd generation transfer plasmids (Imanis products) CANNOT be packaged by 3rd generation systems since 3rd generation systems do not include Tat expression.
> What packaging system should I use with your plasmids to generate lentivirus?
Our lentiviruses are 2nd generation; our lentiviral transfer plasmids are meant to be used in a 3 plasmid 2nd generation packaging system:
- Lentiviral transfer plasmid – the lentiviral plasmid encoding your transgene (ie. pLV-SFFV-hNIS)
- Packaging plasmid - encoding Gag, Pol, Rev, and Tat. Tat is essential for 2nd generation packaging.
- Envelope plasmid – encoding the envelope protein (usually VSV-G)
> How often can I repeat the NIS imaging study in the same subject?
> What are the advantages and disadvantages of using a selection gene?
In vitro: a selection gene allows selection of only cells expressing your gene of interest, creating a fairly homogenous population. This is useful for determining transduction efficiency and expression. In addition, increasing the stringency of selection (by increasing the amount of selection antibiotic in the media) biases toward a population of high expressing cells.
In vivo: selection genes are immunogenic; leading to an immune response that rejects the cells or virus expressing the selection gene. Thus we recommend using selection genes only in immunocompromised mice (nude, SCID, etc).
In general, we recommend using selection genes for in vitro work, but avoiding them for in vivo applications.
> Can I grow the OVs and propagate new stocks in my lab?
about 106 TCID50/mL). Each product will be shipped on dry ice and comes with a certificate of analysis and a protocol for amplification of new viral stocks in your lab.
> Are the OVs well characterized and accurately titered?
> Can NIS be used for long term studies?
> How many times can I NIS image a single subject?
> What is a typical imaging protocol to detect NIS positive cells in a mouse?
Mouse is given 250-300 uCi of SPECT or PET isotopes intravenously (tail vein) or intraperitoneally.
- Wait 1-2 hours.
- Place anesthetized mouse on the imaging bed.
- Image per protocol
> Is NIS safe to use?
> How can NIS technology help me?
> What is NIS?
Products
> What's the source of Imanis's transgenes?
Transgene |
Accession # |
Gene Source |
Description |
---|---|---|---|
Luc2 |
AY738222 |
Photinus pyralis |
Luciferase codon optimized by Promega1. |
hNIS |
U66088 |
Homo sapiens |
Transient NIS expression induces iodide uptake2. |
hNIS I147V |
Mutant of U66088 |
Homo sapiens |
NIS genetically modified by Imanis for enhanced uptake. |
mNIS |
AF235001 |
Mus musculus |
Transient expression induces iodide uptake3. |
rNIS |
U60282.1 |
Rattus norvegicus |
Transient expression induces iodide uptake4. |
pigNIS |
NM214410 |
Sus scrofa |
Transient expression induces iodide uptake5. |
RhNIS |
N/A* |
Rhesus macaque |
Transient expression induces iodide uptake. |
dNIS |
XM_541946 |
Canis lupus |
Transient expression induces iodide uptake6. |
IRES |
M81861 (nt 260 to 848) |
EMCV |
Independent translation of multiple proteins from a single transcript7. |
eGFP |
AAB02572.1 |
Variant of GFP from Aequorea victoria |
100-fold increase in green fluorescent signal as compared to GFP8 |
iRFP |
JN247409 |
Rhodopseudomonas palustris |
Near-infrared fluorescent protein: excitation = 690 emission = 713 nm9. |
dsRed |
AB212907 |
Anopheles gambiae |
Red fluorescent protein variant10 |
DRD2 |
NM_016574.3 |
Homo Sapiens |
GPCR, dopamine receptor variant found in the brain11. |
hNET |
NM_001172501.1 |
Homo Sapiens |
Sodium:neurotransmitter symporter family. Expressed by noradrenergic neurons12. |
SSTR2 |
AY236542.1 |
Homo Sapiens |
Somatostatin receptor. Highest expression in cerebrum and kidneys13. |
HSV-TK |
JQ352282.1 |
HSV |
Human herpesvirus 1 thymidine kinase (UL23)14. |
hTYR |
M27160.1 |
Homo sapiens |
Tyrosinase converts tyrosine to brown-pigmented melanin15 |
1 Promega
2 Smanik et al. Biochem Biophys Res Commun. 1996. 226(2):339-45
3 Pinke et al. Thyroid. 2001. 11(10):935-9
4 Dai et al. Nature. 1996. 379(6564):458-60
5 Selmi-Ruby et al. Endocrinology. 2003. 144(3):1074-85
6 Uyttersprot et al. Mol Cell Endocrinol. 1997. 131(2):195-203
7 Gurtu et al. Biochem Biophys Res Commun. 1996. 229(1):295-8
8 Cormack et al. Gene. 1996. 173(1):33-8
9 Filonov et al. Nat Biotechnol. 2011. 29(8):757-61
10 Baird et al. Proc Natl Acad Sci USA. 2000. 97(22):11984-9
11 Dearry et al. Cell Mol Neurobiol. 1991. 11(5):437-53
12 Pacholczyk et al. Nature. 1991. 350(6316):350-4
13 Parry et al. Mol Imaging. 2007. 6(1):56-67
14 Koehne et al. Nat Biotechnol. 2003. 21(4):405-13
15 Takeda et al. Biochem Biophys Res Commun. 1989. 162(3):984-90
> You have so many antibodies. Which one do I use?
Recommended Imanis antibodies: by target and application
Target |
Western blotting |
Immunofluorescence |
Flow cytometry |
Immunohistochemistry |
||
---|---|---|---|---|---|---|
Intact cells |
Permeabilized cells |
Intact cells |
Permeabilized cells |
|||
Human NIS |
SJ1 (REA004) |
VJ1 (REA002) VJ2 (REA003) |
ETNL (REA009) KELE (REA010)1 |
VJ1 (REA002) VJ2 (REA003) |
ETNL (REA009) Mouse a-hNIS (REA011) |
SJ1 (REA004) KELE (REA010)2 |
Rhesus NIS |
SJ1 (REA004) |
X |
SJ1 (REA004) |
X |
SJ1 (REA004) |
X |
Rat NIS |
α-rat NIS (REA008) |
X |
α-rat NIS (REA008) |
X |
α-rat NIS (REA008) |
α-rat NIS (REA008)3 |
Mouse NIS |
α-rat NIS (REA008) |
X |
α-rat NIS (REA008) |
X |
α-rat NIS (REA008) |
α-rat NIS (REA008)3 |
X = No antibody currently offered for this application.
1Dohan et al. Mol Endoclinol. 2006. 20:1121-1137
2Dohan et al. J Clin Endocrinol Metab. 2001. 86:2697-270
3Tazebay et al. Nat. Med. 2000. 6:871-878
> Can I get the complete sequence of the plasmid transgenes?
We are happy to provide the complete sequence of the plasmid transgenes to our customers upon request. Please email info@imanislife.com.
> How much of your lentivirus should I use for a transduction?
The optimal amount of lentivirus for transduction is cell-type dependent (e.g. primary cells require more virus than established cell lines). We recommend determining the optimal MOI for transduction by plating several wells of the target cells and infecting with increasing MOIs (e.g. 1, 3, 10, and 30*).
*For more information about calculating MOI, please see Cell Biology Protocols.
> Are the OVs well characterized and accurately titered?
> What generation are your lentiviruses? Why does generation matter?
Our lentiviruses are 2nd generation. Generation matters when considering which packaging plasmids to use to produce the lentivirus particles. Briefly, our lentiviral transfer plasmids are meant to be used in a 3 plasmid 2nd generation packaging system:
- Lentiviral transfer plasmid – the lentiviral plasmid encoding your transgene (ie. pLV-SFFV-hNIS)
- Packaging plasmid - encoding Gag, Pol, Rev, and Tat. Tat is essential for 2nd generation packaging.
- Envelope plasmid – encoding the envelope protein (usually VSV-G)
3rd generation lentiviruses encode Gag/Pol and Rev on 2 separate plasmids and the transfer plasmids are Tat independent. Thus 2nd generation transfer plasmids (Imanis products) CANNOT be packaged by 3rd generation systems since 3rd generation systems do not include Tat expression.
> What packaging system should I use with your plasmids to generate lentivirus?
Our lentiviruses are 2nd generation; our lentiviral transfer plasmids are meant to be used in a 3 plasmid 2nd generation packaging system:
- Lentiviral transfer plasmid – the lentiviral plasmid encoding your transgene (ie. pLV-SFFV-hNIS)
- Packaging plasmid - encoding Gag, Pol, Rev, and Tat. Tat is essential for 2nd generation packaging.
- Envelope plasmid – encoding the envelope protein (usually VSV-G)
> What if I need an OV or lentivector not in the product list?
> What is the concentration of your antibodies?
Our antibody concentrations range from 0.4 mg/mL to 1.5 mg/mL. Please refer to the COA shipped with your antibody for recommended dilutions.
> How much does the lentivirus titer drop with freeze-thaw cycles?
Based on in-house studies, lentivirus titers drop approximately 50% with each freeze-thaw cycle.
> Do I need biosafety approval to receive OVs?
Imanis will be able to ship the OVs to you after you have ordered them. However, most institutes require the scientist and lab to have biosafety registration and approval from the institutional biosafety review committee (IBC) prior to using and experimenting with any recombinant viruses. Please treat all oncolytic viruses as a biohazard and take the necessary actions to ensure personnel and environment protection.
For labs in the USA requesting VSV viruses, you will need to obtain a license from the United States Department of Agriculture (USDA) to certify that your lab and personnel are qualified to handle and transport VSV agents. Please refer to the USDA website for more information. NOTE: The VSV offered are derived from cDNA encoding attenuated lab adapted Indian strain of VSV and NOT wild type VSV.
> Can I add my viruses to the repository?
Yes you can! We would love to offer your virus for research use!
Please contact us at info@imanislife.com or call us at +1-507-218-2559 (8:30 am to 5:00 pm, USA Central Time zone) to discuss further.
> Can I grow the OVs and propagate new stocks in my lab?
about 106 TCID50/mL). Each product will be shipped on dry ice and comes with a certificate of analysis and a protocol for amplification of new viral stocks in your lab.
> Can the OVs be administered to animals intravenously?
Yes! The Ovs are suspended in biocompatible media and can be injected intravenously into animals. We suggest dilution of viruses to desired dose level in sterile normal saline and kept on ice until use.
The high titer and high purity viral stocks (listed as High Titer) are prepared specially for in vivo antitumor efficacy experiments. Many of our clients (including our research team) find these high titer stocks very appealing for studies in mice.
> Which viruses are offered?
Services
> What are the acceptable formats for the image analysis files?
> I need help with analyses of my image files!
Shipping
> I live outside the USA. Do I need an import license to receive the viral products?
> Do I need biosafety approval to receive OVs?
Imanis will be able to ship the OVs to you after you have ordered them. However, most institutes require the scientist and lab to have biosafety registration and approval from the institutional biosafety review committee (IBC) prior to using and experimenting with any recombinant viruses. Please treat all oncolytic viruses as a biohazard and take the necessary actions to ensure personnel and environment protection.
For labs in the USA requesting VSV viruses, you will need to obtain a license from the United States Department of Agriculture (USDA) to certify that your lab and personnel are qualified to handle and transport VSV agents. Please refer to the USDA website for more information. NOTE: The VSV offered are derived from cDNA encoding attenuated lab adapted Indian strain of VSV and NOT wild type VSV.
Permits
> Do I need biosafety approval to use your lentivirus?
Check with your institution’s biosafety officer to confirm the requirements of lentivirus use.
Generally, lentiviral work involving animals must have both IBC and IACUC approval, and in vitro lentiviral application should be performed under BSL-2 or BSL-2+ containment practices.
> My biosafety office is asking me about RCV (replication competent virus). What is this?
Replication competent viruses (RCV) are virus particles capable of infection and production of infectious particles. Lentiviral vectors have been engineered to significantly reduce the likelihood of RCV production.
Our lentiviral transfer plasmids are self-inactivating (SIN) vectors in which the viral enhancer and promoter have been deleted. This increases biosafety by preventing mobilization of RCV and enabling regulated expression from the internal promoter without cis-acting effects of the LTR (Miyoshi et al., J Virol. 1998). This safety measure is combined with the 2nd generation packaging system which excludes accessory viral genes necessary for efficient replication and pathogenesis in vivo. Together, these safety precautions should prevent production of RCV.
However, the FDA requires that lentiviral stocks used in human clinical trials be tested for RCV, and some institutions have adopted this in their biosafety protocols. A p24 Gag antigen ELISA assay is most commonly used to demonstrate that there is no increase in p24 titer over time in the media of transduced cells. Imanis offers p24 ELISA RCV testing for lentiviruses, please see this page for more information.
> I live outside the USA. Do I need an import license to receive the viral products?
> Do I need biosafety approval to receive OVs?
Imanis will be able to ship the OVs to you after you have ordered them. However, most institutes require the scientist and lab to have biosafety registration and approval from the institutional biosafety review committee (IBC) prior to using and experimenting with any recombinant viruses. Please treat all oncolytic viruses as a biohazard and take the necessary actions to ensure personnel and environment protection.
For labs in the USA requesting VSV viruses, you will need to obtain a license from the United States Department of Agriculture (USDA) to certify that your lab and personnel are qualified to handle and transport VSV agents. Please refer to the USDA website for more information. NOTE: The VSV offered are derived from cDNA encoding attenuated lab adapted Indian strain of VSV and NOT wild type VSV.
Distribution/Licensing
> Can I add my viruses to the repository?
Yes you can! We would love to offer your virus for research use!
Please contact us at info@imanislife.com or call us at +1-507-218-2559 (8:30 am to 5:00 pm, USA Central Time zone) to discuss further.